Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Increased serum diamine oxidase activity in non-allergic patients with migraine.

< BACK TO ARCHIVE


Papers: 29 Jan 2022 - 4 Feb 2022


Human Studies

PAIN TYPE:
Migraine/Headache


2022 Feb 03


Eur J Clin Invest


http://www.ncbi.nlm.nih.gov/pubmed/35113457?dopt=Abstract

Increased serum diamine oxidase activity in non-allergic patients with migraine.

Authors

Increased serum diamine oxidase activity in non-allergic patients with migraine.
García-Martín E, Navarro-Muñoz S, Amo G, Rodriguez C, Serrador M, Alonso-Navarro H, Calleja M, Turpín-Fenoll L, Recio-Bermejo M, García-Ruiz R, Millán-Pascual J, Navacerrada F, Plaza-Nieto J F, García-Albea E, Agúndez JAG, Jiménez-Jiménez F J
Eur J Clin Invest. 2022 Feb 03:e13757.
PMID: 35113457.

Abstract

Histamine has shown a possible role in the etiopathogenesis of migraine. It has been reported an association between some polymorphisms in the diamine oxidase (DAO) gene and migraine (specially in women). Two studies addressing DAO activity in migraine patients showed conflicting results. We investigated the possible relationship of serum DAO activity and histamine levels and 3 polymorphisms in the DAO gene with the risk for migraine.
Read This Paper